520 related articles for article (PubMed ID: 11158473)
1. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene receptor antagonists and related compounds.
Wenzel SE
Can Respir J; 1999; 6(2):189-93. PubMed ID: 10322101
[TBL] [Abstract][Full Text] [Related]
3. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
4. [Leukotriene modifiers].
Minoguchi K; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
[TBL] [Abstract][Full Text] [Related]
5. [Leukotriene modifiers in the treatment of asthma].
Alvarez J
Rev Alerg Mex; 1999; 46(3):72-7. PubMed ID: 10425884
[TBL] [Abstract][Full Text] [Related]
6. Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients.
Biernacki WA; Kharitonov SA; Biernacka HM; Barnes PJ
Chest; 2005 Oct; 128(4):1958-63. PubMed ID: 16236841
[TBL] [Abstract][Full Text] [Related]
7. New treatments for asthma: the role of leukotriene modifier agents.
Valacer DJ
J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
9. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene modifiers for asthma treatment.
Montuschi P; Peters-Golden ML
Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene-receptor antagonists. Role in asthma management.
D'Urzo AD; Chapman KR
Can Fam Physician; 2000 Apr; 46():872-9. PubMed ID: 10790819
[TBL] [Abstract][Full Text] [Related]
12. Montelukast in pediatric asthma management.
Walia M; Lodha R; Kabra SK
Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
[TBL] [Abstract][Full Text] [Related]
13. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
Bjermer L; Diamant Z
Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
[TBL] [Abstract][Full Text] [Related]
14. Antileukotrienes in clinical development for asthma.
Centanni S; Santus P
Expert Opin Investig Drugs; 2002 Jan; 11(1):49-58. PubMed ID: 11772320
[TBL] [Abstract][Full Text] [Related]
15. Asthma therapy with agents preventing leukotriene synthesis or action.
Drazen JM
Proc Assoc Am Physicians; 1999; 111(6):547-59. PubMed ID: 10591083
[TBL] [Abstract][Full Text] [Related]
16. Asthma pharmacotherapy: an update on leukotriene treatments.
Trinh HKT; Lee SH; Cao TBT; Park HS
Expert Rev Respir Med; 2019 Dec; 13(12):1169-1178. PubMed ID: 31544544
[No Abstract] [Full Text] [Related]
17. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
18. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene modifiers. Expanded role may be on horizon.
Hayden ML
Adv Nurse Pract; 2000 Oct; 8(10):42-6. PubMed ID: 11761536
[No Abstract] [Full Text] [Related]
20. Montelukast: its role in the treatment of childhood asthma.
Harmanci K
Ther Clin Risk Manag; 2007 Oct; 3(5):885-92. PubMed ID: 18473012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
